RCDTF (Recordati SpA) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RCDTF Recordati SpA RCDTF
87 GF Score
Price $58.00
GF Value $70.38
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

RCDTF
87GF Score
Recordati SpA RCDTF
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Recordati SpA (RCDTF) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of $58.00 is trading 17.6% below its estimated GF Value™ of $70.38. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for RCDTF:

  • Interest Received:
  • GF Value™: $70.38 vs. price of $58.00 (17.6% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the RCDTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
87GF Score

Get the complete analysis for RCDTF

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$58.00
Price
$70.38
GF Value